Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
SUSMED, Inc. specializes in healthcare information services, focusing on data analytics and software solutions for healthcare providers primarily in North America. The company leverages its proprietary algorithms to enhance patient outcomes and operational efficiency, setting it apart in a competitive landscape dominated by traditional EMR systems.
SUSMED generates revenue primarily through software licensing and subscription fees for its healthcare analytics platform, which provides actionable insights to healthcare providers. The company's competitive advantage lies in its high gross margin of 97.4%, indicating strong pricing power and operational efficiency. Additionally, its zero debt position enhances financial flexibility.
Adoption rates of SUSMED's software among healthcare providers
Changes in healthcare regulations impacting data reporting requirements
Partnerships with major healthcare systems
Technological advancements in data analytics
Regulatory changes in healthcare data management
Technological disruption from emerging competitors
Increased competition from established EMR providers
Potential market entry by tech giants with healthcare solutions
Negative cash flow impacting operational sustainability
High reliance on a few key clients for revenue
moderate - The healthcare sector is somewhat insulated from economic downturns, but spending on IT services can be affected by overall healthcare budgets.
Low - SUSMED's zero debt position means that rising interest rates do not impact financing costs, but may affect overall healthcare spending.
minimal - The company does not rely on credit for operations, given its strong cash position.
growth - Investors are likely attracted to SUSMED for its high revenue growth potential and innovative product offerings.
high - The stock has shown significant volatility with a 3-month return of -36.3%.
